Download PDF
Am J Perinatol 2018; 35(10): 1012-1022
DOI: 10.1055/s-0038-1635109
Original Article
Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

Genetic Variation, Magnesium Sulfate Exposure, and Adverse Neurodevelopmental Outcomes Following Preterm Birth

Erin A. S. Clark
1   Department of Obstetrics and Gynecology at the University of Utah Health Sciences Center, Salt Lake City, Utah
,
Steven J. Weiner
2   The George Washington University Biostatistics Center, Washington, District of Columbia
,
Dwight J. Rouse
3   Department of Obstetrics and Gynecology, University of Alabama at Birmingham, Birmingham, Alabama
,
Brian M. Mercer
4   Department of Obstetrics and Gynecology, MetroHealth Medical Center-Case Western Reserve University, Cleveland, Ohio
5   Department of Obstetrics and Gynecology, University of Tennessee, Memphis, Tennessee
,
Uma M. Reddy
6   Department of Obstetrics and Gynecology, The Eunice Kennedy Shriver National Institute of Child Health and Human Development, Bethesda, Maryland
,
Jay D. Iams
7   Department of Obstetrics and Gynecology, The Ohio State University, Columbus, Ohio
,
Ronald J. Wapner
8   Department of Obstetrics and Gynecology, Thomas Jefferson University and Drexel University, Philadelphia, Pennsylvania
,
Yoram Sorokin
9   Department of Obstetrics and Gynecology, Wayne State University, Detroit, Michigan
,
Fergal D. Malone
10   Department of Obstetrics and Gynecology, Columbia University, New York, New York
,
Mary J. O'Sullivan
11   Department of Obstetrics and Gynecology, University of Miami, Miami, Florida
,
Alan M. Peaceman
12   Department of Obstetrics and Gynecology, Northwestern University, Chicago, Illinois
,
Gary D. V. Hankins
13   Department of Obstetrics and Gynecology, University of Texas Medical Branch, Galveston, Texas
,
Donald J. Dudley
14   Department of Obstetrics and Gynecology, University of Texas Health Science Center at San Antonio, San Antonio, Texas
,
Steve N. Caritis
15   Department of Obstetrics and Gynecology, University of Pittsburgh, Pittsburgh, Pennsylvania
,
for the Eunice Kennedy Shriver National Institute of Child Health Human Development Maternal-Fetal Medicine Units (MFMU) Network › Author Affiliations Funding The project described was supported by grants from the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) [HD27869, HD34208, HD34116, HD40544, HD27915, HD34136, HD21414, HD27917, HD27860, HD40560, HD40545, HD40485, HD40500, HD27905, HD27861, HD34122, HD40512, HD53907, HD34210, HD21410, HD36801, HD19897]; MO1-RR-000080; and by the National Institute of Neurological Disorders and Stroke (NINDS). Dr. Clark was supported by the National Institutes of Health, National Institute of Child Health and Human Development (K23HD061910). Comments and views of the authors do not necessarily represent views of the NIH.
Further Information

Publication History

21 January 2018

23 January 2018

Publication Date:
06 March 2018 (online)

    Permissions and Reprints

Abstract

Objective To evaluate the association of magnesium sulfate (MgSO4) exposure and candidate gene polymorphisms with adverse neurodevelopmental outcomes following preterm birth.

Study Design We performed a nested case–control analysis of a randomized trial of maternal MgSO4 before anticipated preterm birth for the prevention of cerebral palsy (CP). Cases were children who died within 1 year of life or were survivors with abnormal neurodevelopment at age 2 years. Controls were race- and sex-matched survivors with normal neurodevelopment. We analyzed 45 candidate gene polymorphisms in inflammation, coagulation, and vascular regulation pathways and their association with (1) psychomotor delay, (2) mental delay, (3) CP, and (4) combined outcome of death/CP. Logistic regression analyses, conditional on maternal race and child sex, and adjusted for treatment group, gestational age at birth and maternal education, were performed.

Results Four hundred and six subjects, 211 cases and 195 controls, were analyzed. The strongest association was for IL6R (rs 4601580) in which each additional copy of the minor allele was associated with an increased risk of psychomotor delay (adjusted odds ratio 3.3; 95% confidence interval, 1.7–6.5; p < 0.001).

Conclusion Candidate gene polymorphisms are associated with death and adverse neurodevelopmental outcomes following preterm birth. MgSO4 may abrogate this genotype association for some loci.

Keywords

candidate genes - magnesium sulfate - mental developmental delay - neurodevelopmental delay - preterm birth - polymorphisms - psychomotor delay - single-nucleotide polymorphisms

* The members of the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) Maternal-Fetal Medicine Units Network are listed in the Appendix.


 

  • References

  • 1 Rouse DJ, Hirtz DG, Thom E. , et al; Eunice Kennedy Shriver NICHD Maternal-Fetal Medicine Units Network. A randomized, controlled trial of magnesium sulfate for the prevention of cerebral palsy. N Engl J Med 2008; 359 (09) 895-905
    CrossrefPubMedGoogle Scholar
  • 2 Crowther CA, Hiller JE, Doyle LW, Haslam RR. ; Australasian Collaborative Trial of Magnesium Sulphate (ACTOMg SO4) Collaborative Group. Effect of magnesium sulfate given for neuroprotection before preterm birth: a randomized controlled trial. JAMA 2003; 290 (20) 2669-2676
    CrossrefPubMedGoogle Scholar
  • 3 Marret S, Marpeau L, Bénichou J. Benefit of magnesium sulfate given before very preterm birth to protect infant brain. Pediatrics 2008; 121 (01) 225-226
    CrossrefPubMedGoogle Scholar
  • 4 Costantine MM, Weiner SJ. ; Eunice Kennedy Shriver National Institute of Child Health and Human Development Maternal-Fetal Medicine Units Network. Effects of antenatal exposure to magnesium sulfate on neuroprotection and mortality in preterm infants: a meta-analysis. Obstet Gynecol 2009; 114 (2 Pt 1): 354-364
    CrossrefPubMedGoogle Scholar
  • 5 Doyle LW, Crowther CA, Middleton P, Marret S. Antenatal magnesium sulfate and neurologic outcome in preterm infants: a systematic review. Obstet Gynecol 2009; 113 (06) 1327-1333
    Google Scholar
  • 6 Marret S, Doyle LW, Crowther CA, Middleton P. Antenatal magnesium sulphate neuroprotection in the preterm infant. Semin Fetal Neonatal Med 2007; 12 (04) 311-317
    CrossrefPubMedGoogle Scholar
  • 7 Hirtz DG, Nelson K. Magnesium sulfate and cerebral palsy in premature infants. Curr Opin Pediatr 1998; 10 (02) 131-137
    CrossrefPubMedGoogle Scholar
  • 8 Gomez R, Romero R, Ghezzi F, Yoon BH, Mazor M, Berry SM. The fetal inflammatory response syndrome. Am J Obstet Gynecol 1998; 179 (01) 194-202
    Google Scholar
  • 9 Romero R, Gomez R, Ghezzi F. , et al. A fetal systemic inflammatory response is followed by the spontaneous onset of preterm parturition. Am J Obstet Gynecol 1998; 179 (01) 186-193
    CrossrefPubMedGoogle Scholar
  • 10 Yoon BH, Jun JK, Romero R. , et al. Amniotic fluid inflammatory cytokines (interleukin-6, interleukin-1beta, and tumor necrosis factor-alpha), neonatal brain white matter lesions, and cerebral palsy. Am J Obstet Gynecol 1997; 177 (01) 19-26
    CrossrefPubMedGoogle Scholar
  • 11 Yoon BH, Romero R, Park JS. , et al. Fetal exposure to an intra-amniotic inflammation and the development of cerebral palsy at the age of three years. Am J Obstet Gynecol 2000; 182 (03) 675-681
    CrossrefPubMedGoogle Scholar
  • 12 Yoon BH, Park CW, Chaiworapongsa T. Intrauterine infection and the development of cerebral palsy. BJOG 2003; 110 (Suppl. 20) 124-127
    CrossrefPubMedGoogle Scholar
  • 13 Gibson CS, Maclennan AH, Dekker GA. , et al. Candidate genes and cerebral palsy: a population-based study. Pediatrics 2008; 122 (05) 1079-1085
    CrossrefPubMedGoogle Scholar
  • 14 Gibson CS, MacLennan AH, Goldwater PN, Haan EA, Priest K, Dekker GA. ; South Australian Cerebral Palsy Research Group. The association between inherited cytokine polymorphisms and cerebral palsy. Am J Obstet Gynecol 2006; 194 (03) 674.e1-674.e11
    CrossrefPubMedGoogle Scholar
  • 15 Nelson KB, Dambrosia JM, Iovannisci DM, Cheng S, Grether JK, Lammer E. Genetic polymorphisms and cerebral palsy in very preterm infants. Pediatr Res 2005; 57 (04) 494-499
    CrossrefPubMedGoogle Scholar
  • 16 Wu YW, Croen LA, Torres AR, Van De Water J, Grether JK, Hsu NN. Interleukin-6 genotype and risk for cerebral palsy in term and near-term infants. Ann Neurol 2009; 66 (05) 663-670
    CrossrefPubMedGoogle Scholar
  • 17 Clark EA, Mele L, Wapner RJ. , et al; Eunice Kennedy Shriver National Institute of Child Health and Human Development Maternal-Fetal Medicine Units Network. Association of fetal inflammation and coagulation pathway gene polymorphisms with neurodevelopmental delay at age 2 years. Am J Obstet Gynecol 2010; 203 (01) 83.e1-83.e10
    CrossrefPubMedGoogle Scholar
  • 18 Harding D, Brull D, Humphries SE, Whitelaw A, Montgomery H, Marlow N. Variation in the interleukin-6 gene is associated with impaired cognitive development in children born prematurely: a preliminary study. Pediatr Res 2005; 58 (01) 117-120
    CrossrefPubMedGoogle Scholar
  • 19 Harding DR, Dhamrait S, Whitelaw A, Humphries SE, Marlow N, Montgomery HE. Does interleukin-6 genotype influence cerebral injury or developmental progress after preterm birth?. Pediatrics 2004; 114 (04) 941-947
    CrossrefPubMedGoogle Scholar
  • 20 Guo SW, Thompson EA. Performing the exact test of Hardy-Weinberg proportion for multiple alleles. Biometrics 1992; 48 (02) 361-372
    CrossrefPubMedGoogle Scholar
  • 21 Costantine MM, Clark EA, Lai Y. , et al. Association of polymorphisms in neuroprotection and oxidative stress genes and neurodevelopmental outcomes after preterm birth. Obstet Gynecol 2012; 120 (03) 542-550
    CrossrefPubMedGoogle Scholar
  • 22 Wu D, Zou YF, Xu XY. , et al. The association of genetic polymorphisms with cerebral palsy: a meta-analysis. Dev Med Child Neurol 2011; 53 (03) 217-225
    CrossrefPubMedGoogle Scholar
  • 23 Khankhanian P, Baranzini SE, Johnson BA. , et al. Sequencing of the IL6 gene in a case-control study of cerebral palsy in children. BMC Med Genet 2013; 14: 126
    CrossrefPubMedGoogle Scholar
  • 24 Velez DR, Fortunato SJ, Williams SM, Menon R. Interleukin-6 (IL-6) and receptor (IL6-R) gene haplotypes associate with amniotic fluid protein concentrations in preterm birth. Hum Mol Genet 2008; 17 (11) 1619-1630
    CrossrefPubMedGoogle Scholar
  • 25 Gibson CS, MacLennan AH, Goldwater PN, Haan EA, Priest K, Dekker GA. ; South Australian Cerebral Palsy Research Group. Mannose-binding lectin haplotypes may be associated with cerebral palsy only after perinatal viral exposure. Am J Obstet Gynecol 2008; 198 (05) 509.e1-509.e8
    CrossrefPubMedGoogle Scholar
  • 26 Auriti C, Prencipe G, Caravale B. , et al. MBL2 gene polymorphisms increase the risk of adverse neurological outcome in preterm infants: a preliminary prospective study. Pediatr Res 2014; 76 (05) 464-469
    CrossrefPubMedGoogle Scholar
  • 27 Orsini F, Villa P, Parrella S. , et al. Targeting mannose-binding lectin confers long-lasting protection with a surprisingly wide therapeutic window in cerebral ischemia. Circulation 2012; 126 (12) 1484-1494
    CrossrefPubMedGoogle Scholar
  • 28 Osthoff M, Katan M, Fluri F. , et al. Mannose-binding lectin deficiency is associated with smaller infarction size and favorable outcome in ischemic stroke patients. PLoS One 2011; 6 (06) e21338
    CrossrefPubMedGoogle Scholar
  • 29 Cervera A, Planas AM, Justicia C. , et al. Genetically-defined deficiency of mannose-binding lectin is associated with protection after experimental stroke in mice and outcome in human stroke. PLoS One 2010; 5 (02) e8433
    CrossrefPubMedGoogle Scholar
  • 30 Arbour NC, Lorenz E, Schutte BC. , et al. TLR4 mutations are associated with endotoxin hyporesponsiveness in humans. Nat Genet 2000; 25 (02) 187-191
    CrossrefPubMedGoogle Scholar
  • 31 Agnese DM, Calvano JE, Hahm SJ. , et al. Human toll-like receptor 4 mutations but not CD14 polymorphisms are associated with an increased risk of gram-negative infections. J Infect Dis 2002; 186 (10) 1522-1525
    CrossrefPubMedGoogle Scholar
  • 32 Djukic M, Gibson CS, Maclennan AH. , et al. Genetic susceptibility to viral exposure may increase the risk of cerebral palsy. Aust N Z J Obstet Gynaecol 2009; 49 (03) 247-253
    CrossrefPubMedGoogle Scholar
  • 33 Kapitanović Vidak H, Catela Ivković T, Jokić M, Spaventi R, Kapitanović S. The association between proinflammatory cytokine polymorphisms and cerebral palsy in very preterm infants. Cytokine 2012; 58 (01) 57-64
    CrossrefPubMedGoogle Scholar
  • 34 O'Callaghan ME, Maclennan AH, Gibson CS. , et al; Australian Collaborative Cerebral Palsy Research Group. Genetic and clinical contributions to cerebral palsy: a multi-variable analysis. J Paediatr Child Health 2013; 49 (07) 575-581
    CrossrefPubMedGoogle Scholar
  • 35 Li J, Ji L. Adjusting multiple testing in multilocus analyses using the eigenvalues of a correlation matrix. Heredity (Edinb) 2005; 95 (03) 221-227
    CrossrefPubMedGoogle Scholar